← SynDRA
SENAPARIB
SynDRA canonical compound SYN0040265 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PARP1 |
|---|
| Mechanism of action | parp inhibitor |
|---|
| Indication | breast cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- PARP1 INHIBITOR
- Poly [ADP-ribose] polymerase-1 inhibitor
- PARP2 INHIBITOR
- Poly [ADP-ribose] polymerase 2 inhibitor
- PARP inhibitor
Cross-references
Synonyms
- IMP4297
- IMP-4297
- IMP 4297
- MNZ4OP95CF
- RefChem:182371
- PARP 1/2 Inhibitor IMP4297
- Senaparib [INN]
- UNII-MNZ4OP95CF
- Senaparib (INN)
- Paishuning (China)
- SENAPARIB [WHO-DD]
- orb1297996
- SCHEMBL12822522
- SCHEMBL29371993
- SCHEMBL29549403
- GTPL11199
- GLXC-26911
- IMP4297;JS109
- EX-A10409
- AKOS040759892
- MS-28879
- HY-137450
- CS-0138656
- D13232
- G17601
- orb1738718
- Senaparib hydrochloride
- EX-A10409A
- IMP-4297 hydrochloride
- IP7DV1DQ1R
- SCHEMBL30543533
- SCHEMBL15420063
- UNII-IP7DV1DQ1R
Look up SENAPARIB in the interactive SynDRA portal →